Treatment of cancer cells with DNA methyltransferase inhibitors (DNMTis) activates RNA sensors, including MDA5 and the endosomal dsRNA sensor Toll‐like receptor 3 (TLR3) (Chiappinelli et al, 2015; Roulois et al, 2015). The gene discussed is TLR3; the disease is cancer.